FDA Issues Class I Recall for ResMed Astral 100/150 Ventilators

AI-generated NewsSnap summary based on source reporting.
Published: 2026-07-31
Category: health
Source: U.S. Food and Drug Administration (FDA)
Original source

The FDA has designated an issue with certain ResMed Astral 100 and 150 ventilators as a Class I recall, the most serious type. A leaking internal supercapacitor can damage the circuit board, potentially causing the device to fail and interrupt ventilation therapy. This defect poses a risk of serious adverse health consequences or death. Healthcare providers must acknowledge a correction form and reinforce safety measures, including backup ventilation.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai